Epilepsy and Seizure Disorders affect over 50 million people worldwide and represent a diverse group of neurological conditions characterized by recurrent, unprovoked seizures. This session at the Neurology Conference provides a comprehensive overview of seizure classification, neurobiological mechanisms, and modern diagnostic approaches. Participants will explore how genetic mutations, structural brain abnormalities, autoimmune processes, metabolic disturbances, and network-level dysfunction contribute to epileptogenesis. Special focus will be given to advances in electroencephalography (EEG), video-EEG monitoring, and high-resolution neuroimaging techniques that improve diagnostic accuracy and seizure localization. The session will also address differential diagnosis, seizure mimics, and the challenges of early identification, particularly in pediatric and elderly populations.
The session further examines contemporary treatment strategies aimed at achieving seizure freedom and improving quality of life. Updates on antiseizure medications, pharmacogenomics, and personalized therapy selection will be discussed, alongside management of drug-resistant epilepsy. Experts will present current evidence on epilepsy surgery, laser ablation, and neuromodulation therapies such as vagus nerve stimulation, deep brain stimulation, and responsive neurostimulation. In addition, the session highlights psychosocial aspects of epilepsy, including comorbidities, cognitive impact, stigma, and mental health considerations. Emerging research on disease-modifying therapies, digital seizure tracking, wearable devices, and artificial intelligence–driven prediction models will also be explored. By integrating basic science, clinical practice, and innovative technologies, this session equips neurologists, epileptologists, researchers, and allied healthcare professionals with up-to-date knowledge to optimize epilepsy care and advance future research.
Key Highlights
Why This Session Is Important?
Epilepsy is a lifelong condition with significant medical, psychological, and social implications. This session is essential for improving diagnostic accuracy, expanding treatment options for drug-resistant cases, and enhancing patient-centered care to reduce seizure burden and improve quality of life.